Arcus Biosciences, Inc. - Common Stock, par value $0.0001 (RCUS)

CUSIP: 03969F109

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 7 signals
Share change
-106,618
Put/Call ratio
62%
SEC-reported price per share
$25.96
Number of holders
143
Value change
+$10,417,742
Number of buys
74
Open additional details 1 more signal available
Number of sells
66
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
127,225,749

Security key

03969F109

Report period

Q4 2020

Institutions

143

Top holders

10

Ownership snapshot

Top reported holders of RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Alphabet Inc.
Disclosed value leader
Alphabet Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2020
13F Highest disclosed value: $86,553,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Alphabet Inc. has the largest disclosed position value at $86.55M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Alphabet Inc.'s linked filing trail.
Disclosed position value Top 5
Alphabet Inc. $86.55M
BlackRock Finance, Inc. $53.64M
BVF INC/IL $44.52M
PFM Health Sciences, LP $43.48M
STATE STREET CORP $43.17M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Alphabet Inc.
13F
Company
13F
—
denominator unverified
$86,553,000
5,049,786 shares
— 30 Sep 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$53,636,000
3,129,282 shares
— 30 Sep 2020
BVF INC/IL
13F
Company
13F
—
denominator unverified
$44,516,000
2,597,222 shares
— 30 Sep 2020
PFM Health Sciences, LP
13F
Company
13F
—
denominator unverified
$43,483,000
2,536,932 shares
— 30 Sep 2020
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$43,167,000
2,518,468 shares
— 30 Sep 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$40,295,000
2,350,942 shares
— 30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
143
Shares
44,575,673
Rows available
143
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
127
Q4 2020 holders
143
Holder diff
16
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .